Best Supplements for Visceral Hypersensitivity & Gut Pain: The Complete Evidence-Based Stack

If a normal volume of gas in your colon registers as a sharp pain or doubles you over with cramping; if you have been diagnosed with IBS-C, IBS-D, or IBS-M and the dominant feature is pain rather than bowel pattern; if eating a "normal" meal — even a low-FODMAP one — produces a level of discomfort that seems out of proportion to what could possibly be happening biologically; if you have been told by multiple physicians that your endoscopy, colonoscopy, and imaging are normal but you are still in pain — you are likely living with a Visceral Sensitivity (VH) pattern. Visceral hypersensitivity is one of the most distressing of the 12 GutIQ patterns to live with and one of the most under-validated by traditional medicine. The pain is real, the physiological substrate is real (peripheral and central sensitization of visceral afferent neurons), and the path to relief is real — but it almost never lies in any single intervention. It is a multi-mechanism stack of gut-brain-axis tools.

This guide is the practical companion to the Visceral Sensitivity Pattern overview and the Foods for Visceral Sensitivity food strategy on GutIQ, and it focuses on exactly which supplements work, how to dose them, when to take them, and how to stack them safely. The supplement role in VH is sixfold. First, direct smooth-muscle and visceral-pain modulation with enteric-coated peppermint oil, the supplement with the largest body of trial evidence in IBS-related visceral pain. Second, microbiome modulation of pain signaling with strain-specific probiotics — especially Bifidobacterium infantis 35624, which has direct evidence for visceral pain reduction. Third, nervous-system anti-inflammatory support with palmitoylethanolamide (PEA), magnesium glycinate, and omega-3s. Fourth, gut-brain axis modulation with saffron, L-theanine, and adaptogenic herbs. Fifth, epithelial barrier and inflammation with L-glutamine, zinc carnosine, and curcumin where appropriate. Sixth, combination with non-pharmacological gut-brain interventions — gut-directed hypnotherapy, cognitive behavioral therapy for IBS, and breathing practices — because no supplement stack reaches its full potential without these complementary interventions.

Why does this matter so much for the VH pattern specifically? Because the dominant medical approach is symptom-suppression with antispasmodics (dicyclomine, hyoscyamine), tricyclic antidepressants at low doses, or SSRIs — all of which can help but address symptoms rather than the underlying gut-brain axis dysregulation. The right framework is to address peripheral sensitization (with peppermint oil, probiotics, gut barrier support), central sensitization (with gut-brain axis supplements and hypnotherapy), and the chronic stress amplifier (with magnesium, adaptogens, vagal tone work) together. Within 8-12 weeks of starting the VH stack combined with gut-directed hypnotherapy or CBT, most VH patients see a 50%+ reduction in pain frequency and severity. This is the central goal of this protocol.

The evidence base for visceral-sensitivity supplementation is more robust than the diagnosis is acknowledged. Enteric-coated peppermint oil has multiple meta-analyses confirming efficacy in IBS with effect sizes comparable to or larger than most prescription options. Bifidobacterium infantis 35624 has the most rigorous probiotic evidence in IBS. Iberogast has strong functional-dyspepsia and IBS data. PEA has emerging evidence in visceral pain. L-glutamine has trial evidence specifically in post-infectious IBS. Saffron has emerging IBS trial data and strong gut-brain mood evidence. The cited literature includes specific RCTs and meta-analyses.

This guide is for you if any of the following apply: you scored highest on the Visceral Sensitivity pattern in the GutIQ quiz; you have been diagnosed with IBS where pain is a dominant feature; you have post-infectious IBS following a gastrointestinal infection; you have functional abdominal pain syndrome (FAPS); you have endometriosis or pelvic floor dysfunction with overlapping visceral pain; you have been told your tests are "normal" but you continue to have pain; you have chronic gut pain that worsens with stress; or you are looking to complement an existing low-dose tricyclic, SSRI, or antispasmodic regimen with evidence-based supplements.

What follows organizes supplements into three tiers — Foundation, Pattern-Specific, and Advanced/Optional — with each entry covering mechanism, dose, timing, evidence quality, side effects, and which patients benefit most. We then cover what to avoid, a sample 4-week stacking schedule, drug interactions, cost-tier shopping, how to test if your protocol is working, a severe chronic-pain-IBS intensive protocol, and an FAQ. By the end you will have a complete, sequenced supplement plan you can start tomorrow.

Critical context: Visceral hypersensitivity is a diagnosis of structural-and-inflammatory exclusion. Before assuming VH, ensure adequate workup has excluded inflammatory bowel disease, celiac disease, pelvic floor disorders, endometriosis, gynecological causes (in women), interstitial cystitis, and chronic pancreatitis. The supplements in this guide are for documented VH or strong clinical suspicion after structural workup; they are not a substitute for diagnostic workup of new abdominal pain.

Tier 1 — Foundation: Start Here

These five interventions are the evidence-based foundation of visceral-sensitivity supplementation. Most VH patients achieve clinically meaningful improvement (50%+ reduction in pain episode frequency and severity, ability to expand diet, reduced anticipatory anxiety around eating) with the foundation tier alone, often within 6-12 weeks. Add Tier 1 in this order, allowing 7-14 days between additions so you can attribute effects in a high-noise symptom environment.

Enteric-coated peppermint oil, 0.2 mL (180-225 mg) two-three times daily before meals

Mechanism: Peppermint oil's active components (primarily menthol) are direct calcium-channel antagonists on intestinal smooth muscle, producing antispasmodic effects similar to but more selective than prescription antispasmodics. They also have direct visceral-pain receptor effects via TRPM8 cool-receptor modulation, mildly antimicrobial effects on small intestinal bacteria, and anti-inflammatory effects on intestinal epithelium. The enteric coating is essential — uncoated peppermint oil dissolves in the stomach, can worsen reflux, and never reaches the colon where the IBS smooth muscle is.

Evidence: The Khanna et al. 2014 meta-analysis in Journal of Clinical Gastroenterology pooled 9 RCTs of enteric-coated peppermint oil in IBS and found significant improvement in global IBS symptoms and abdominal pain, with a number-needed-to-treat of 3 and a strong safety profile. The 2019 systematic review by Alammar et al. confirmed efficacy. The American College of Gastroenterology IBS guidelines list peppermint oil as a recommended first-line agent.

Dose and form: 0.2 mL (180-225 mg) enteric-coated peppermint oil, 2-3 times daily, taken 30 minutes before main meals. Recommended products: IBgard (FDA-cleared medical food, microspherules with sustained intestinal release), Pepogest (Nature's Way), Heather's Tummy Tamers. Look for "enteric-coated" or "sustained-release" — bulk peppermint oil drops or essential oils are not interchangeable.

Timing: 30 minutes before main meals. Use consistently for at least 4 weeks before assessing response — peppermint oil works gradually for some patients.

Cautions: Heartburn or reflux at high doses or with non-enteric-coated formulations — switch to enteric-coated only. Anal burning at very high doses (rare). Use cautiously in active GERD; the enteric-coated form is acceptable for most reflux patients. Pregnancy and lactation: discuss with a healthcare provider; small studies suggest safety but data is limited. Severe gastroesophageal reflux is a relative contraindication unless using sustained-release microspherule form.

Bifidobacterium infantis 35624, 1 billion CFU daily

Mechanism: Bifidobacterium infantis 35624 (sold as Align in the US) is the single most rigorously studied probiotic strain in IBS. It modulates the gut-immune axis (specifically TNF-alpha, IL-6, IL-12), reduces visceral afferent firing, and has demonstrable effects on gut-brain signaling that translate to symptomatic pain reduction in clinical trials. The mechanism is fundamentally about pain processing rather than the broad "gut health" claims of generic probiotics.

Evidence: The O'Mahony et al. 2005 trial in Gastroenterology and the Whorwell et al. 2006 trial in American Journal of Gastroenterology established efficacy in IBS — both showed significant improvement in global IBS symptoms, abdominal pain, and bloating in placebo-controlled designs. Subsequent trials and meta-analyses confirm the strain-specific signal. Few probiotic strains have this level of trial evidence; most IBS probiotic recommendations rest on this strain plus a small number of others.

Dose and form: Align Probiotic Supplement, 1 capsule (1 billion CFU of B. infantis 35624) once daily. Take consistently. Effects develop over 4-6 weeks.

Timing: Any time, with or without food. AM with breakfast is convenient.

Cautions: Very safe. Discontinue and seek care if any unexpected systemic infection in immunocompromised states. Mild bloating or initial GI changes in the first week resolve.

Iberogast (STW-5), 20 drops three times daily before meals

Mechanism: Iberogast is a nine-herb combination with empirically validated effects on gastric motility, smooth muscle tone, and visceral pain. It relaxes hypertonic regions of the gut while stimulating hypotonic regions — a tissue-specific effect particularly valuable in mixed IBS where pain comes from both spasm (hypertonic) and stretch (hypotonic) in different gut segments.

Evidence: Over 80 published trials. The Madisch et al. 2004 meta-analysis showed efficacy in functional dyspepsia and IBS. The 2024 Allescher et al. systematic review confirmed the effect size.

Dose and form: 20 drops in water, 3 times daily, 15-30 minutes before meals. Liquid only.

Cautions: Contains alcohol. Rare hepatotoxicity case reports related to celandine component — for prolonged continuous use (more than 6 months), periodic liver enzyme check is reasonable. Pregnancy and lactation: discuss with a healthcare provider.

Magnesium glycinate, 300-400 mg elemental, evening

Mechanism: Magnesium has direct effects on smooth muscle (relaxant), nervous system (GABAergic modulation), sleep quality, and parasympathetic vagal tone. In VH patterns where central nervous system sensitization is part of the pain experience, magnesium glycinate addresses multiple contributors simultaneously. The glycinate form is preferred over citrate or oxide because the goal is nervous-system support, not laxation.

Evidence: Magnesium repletion improves sleep quality (Abbasi 2012), reduces cortisol response to stress, and supports vagal tone. Magnesium deficiency is associated with pain hypersensitivity in chronic pain conditions (Bagis 2013 in fibromyalgia). The VH-specific case is mechanistic; broader pain-modulation evidence is moderate.

Dose and form: 300-400 mg elemental magnesium as glycinate, bisglycinate, or malate, taken 30-60 minutes before bed. Avoid magnesium oxide.

Timing: Evening, 30-60 minutes before bed.

Cautions: Reduce in kidney disease. If stool loosens, reduce dose by 100 mg or split AM/PM.

L-glutamine, 5-10 g daily on empty stomach

Mechanism: L-glutamine is the preferred fuel for enterocytes. In post-infectious IBS (PI-IBS), where visceral hypersensitivity often persists for months to years after a gastrointestinal infection, intestinal barrier dysfunction (often called "leaky gut") contributes to ongoing low-grade inflammation and immune activation. L-glutamine repletion supports barrier recovery, reduces tight-junction defect markers, and has shown direct improvement in PI-IBS symptoms in trials.

Evidence: The Zhou et al. 2019 trial in Gut — a randomized, double-blind, placebo-controlled trial of 5 g L-glutamine three times daily versus placebo in 106 patients with PI-IBS-D — showed significant reduction in IBS symptoms, with 80% of glutamine group achieving substantial improvement versus 6% of placebo. This is one of the most striking single-trial signals in IBS supplementation.

Dose and form: 5 g L-glutamine powder mixed in water on empty stomach, twice or three times daily (10-15 g total). Pure L-glutamine powder is most cost-effective; capsules are convenient. Use for 12-week courses initially.

Timing: Empty stomach — first thing in morning, mid-afternoon, and at bedtime work well.

Cautions: Very safe. Pause in hepatic encephalopathy. Pregnancy: discuss with a healthcare provider.

Tier 2 — Pattern-Specific: Gut-Brain Axis & Nerve Support

These four agents target gut-brain axis modulation, peripheral nerve sensitization, and the central pain-processing component of VH. Consider adding one or two once Tier 1 is well-established (after 4-6 weeks). They are particularly valuable when Tier 1 has produced partial response.

Saffron extract, 28-30 mg daily

Why for VH: Saffron has strong evidence in mood disorders and emerging evidence in IBS. It modulates serotonergic signaling (relevant to both mood and gut motility), has anti-inflammatory effects, and works on the gut-brain axis from both ends. Particularly valuable for VH patterns with overlapping anxiety or depression, which are present in 30-60% of IBS patients.

Evidence: Multiple trials show saffron's effect on depression and anxiety. The Aalipour et al. 2024 trial in Journal of Functional Foods showed saffron extract improved IBS symptoms including pain and quality of life. Earlier work by Bani et al. 2014 also supports IBS use.

Dose and form: 28-30 mg standardized saffron extract daily, taken with breakfast. Affron (Pharmactive Biotech) is the most studied branded extract; many products use this. Look for "Affron" on the label or comparable lepticrocin/crocin standardization.

When to add: Especially valuable when VH overlaps with mood symptoms.

Cautions: Generally safe at standard doses. Avoid pregnancy (very high doses are uterine-stimulant). May modestly potentiate SSRI effects; discuss with prescriber.

Palmitoylethanolamide (PEA), 600-1,200 mg daily

Why for VH: PEA is an endogenous fatty-acid amide with documented anti-inflammatory and analgesic effects mediated through peroxisome proliferator-activated receptor alpha (PPAR-α) and indirect cannabinoid receptor modulation. It reduces mast cell activation, which is relevant in visceral hypersensitivity. Particularly valuable in patients with overlapping endometriosis, pelvic pain, or fibromyalgia.

Evidence: Multiple trials in chronic pain conditions show analgesic and anti-inflammatory effects. The Schifilliti et al. 2014 trial demonstrated benefit in diabetic neuropathy. Emerging IBS-specific trials are growing. The Cremon et al. 2017 trial showed PEA-polydatin combination improved IBS abdominal pain.

Dose and form: 600-1,200 mg daily, split AM and PM. Micronized PEA (Pelvilen, Normast, PeaPure) has better bioavailability than non-micronized. PEA is sold OTC in some countries and as a medical food in others.

When to add: Especially valuable for VH overlap with endometriosis, fibromyalgia, or interstitial cystitis. Reasonable after 4 weeks of Tier 1 if pain persists.

Cautions: Very safe. No significant drug interactions.

Curcumin (high-bioavailability form), 500 mg twice daily

Why for VH: Curcumin reduces low-grade systemic inflammation, has direct anti-nociceptive effects, and modulates the gut-brain axis. In VH patterns where systemic inflammation contributes to peripheral sensitization, curcumin adds a useful anti-inflammatory layer.

Evidence: Multiple trials in inflammatory pain conditions. The Niederreiter et al. 2017 trial in IBS showed curcumin reduced abdominal pain and improved quality of life. Earlier work by Bundy et al. 2004 in IBS also showed benefit.

Dose and form: 500 mg high-bioavailability curcumin (Meriva, BCM-95, Theracurmin, or Longvida) twice daily with meals. Plain turmeric powder or low-bioavailability extracts are not adequate.

Cautions: Mild antiplatelet effect. Pause before surgery. Theoretical interaction with cyclosporine and tacrolimus.

Omega-3 (high-EPA), 2,000-3,000 mg combined EPA+DHA daily

Why for VH: EPA and DHA are precursors to specialized pro-resolving mediators that actively resolve inflammation. They have documented effects on visceral pain processing, gut barrier function, and microbiome composition. Higher doses than the maintenance dose are appropriate for active pain conditions.

Evidence: The Wallace et al. 2020 review summarized omega-3's anti-inflammatory effects across pain conditions. The Watson et al. 2018 trial in Gut showed favorable microbiome shifts.

Dose and form: 2,000-3,000 mg combined EPA+DHA daily. Higher EPA-to-DHA ratios (2:1 or higher) are preferred for inflammatory and pain modulation. Choose IFOS-certified, triglyceride-form products.

Cautions: Antiplatelet effect at higher doses. Pause 7-10 days before surgery. Discuss with anticoagulant prescriber.

Tier 3 — Advanced/Optional: Adjuncts, Gut-Directed Hypnotherapy & Severe Cases

Gut-directed hypnotherapy (GDH) — the most evidence-based non-pharmacological intervention in VH

Why for VH: Of all interventions in IBS with visceral hypersensitivity, gut-directed hypnotherapy has perhaps the largest body of trial evidence — effect sizes comparable to or larger than most medications and supplements. It directly addresses the central sensitization component that supplements cannot fully reach. It is not "alternative" — major IBS guidelines and gastroenterology centers explicitly recommend it.

Evidence: The Peters et al. 2016 trial in Alimentary Pharmacology and Therapeutics, the Whorwell IBS hypnotherapy work over decades, and the Manchester and Nord-Trondelag protocols all establish efficacy. NICE guidelines (UK) and ACG guidelines (US) recommend it.

How to access:

• Nerva (app) — 6-week structured gut-directed hypnotherapy program developed by Mindset Health with the Monash IBS team, with trial evidence (Peters et al. 2024)
• Mahana IBS (formerly Cara Care) — similar app-based protocol
• In-person GDH therapist — search directories from clinical hypnosis societies (ASCH in US, BSCH in UK)

Time commitment: 15-20 minutes per day for 6-12 weeks for initial benefit; periodic maintenance practice for long-term effect retention.

CBT for IBS

Cognitive behavioral therapy for IBS specifically (not generic CBT) has substantial evidence for symptom and quality-of-life improvement. The ACTRIB protocol and Mahana IBS app are validated approaches. Complements the supplement stack particularly well for VH patterns with anxiety overlap.

Low-dose tricyclic antidepressants (prescription) — for severe VH

When: Pain remains significant despite 8-12 weeks of well-conducted Tier 1-2 plus hypnotherapy or CBT.

Options:

• Amitriptyline 10-25 mg at bedtime — most evidence in IBS-D
• Nortriptyline 10-25 mg at bedtime — fewer anticholinergic side effects
• Desipramine 25-50 mg at bedtime — relatively selective for noradrenergic effects

Tricyclics at these low doses are used for their visceral analgesic and sleep effects rather than antidepressant doses (75-150 mg). Coordinate with primary care or gastroenterologist.

SSRIs (prescription) — for VH with mood overlap

Particularly effective when VH has substantial anxiety or depression overlap. Sertraline, citalopram, escitalopram are common choices. SSRIs may worsen diarrhea in IBS-D — choose drug class based on bowel pattern.

Linaclotide, lubiprostone, or eluxadoline (prescription) — for IBS-C or IBS-D with pain

FDA-approved IBS-specific medications with documented pain benefit beyond bowel-pattern effects. Linaclotide and lubiprostone for IBS-C with pain; eluxadoline for IBS-D with pain.

Berberine 500 mg three times daily — for SIBO/dysbiosis overlap

When VH overlaps with bacterial overgrowth (positive breath test, post-infectious IBS history, response to rifaximin in past), berberine has direct antimicrobial activity and clinical evidence in SIBO. Course of 4-8 weeks. Coordinate with clinician for diagnosis.

What to Avoid in Visceral Sensitivity Patterns

Caffeine (especially in excess)

Caffeine increases gut motility and visceral afferent firing. For most VH patients, 1-2 cups of coffee/day is tolerated; greater than 2 cups frequently worsens pain. Try a 2-week caffeine elimination to test individual sensitivity. Decaf is generally tolerated.

Alcohol

Alcohol disrupts intestinal barrier, alters microbiome, worsens sleep, and amplifies anxiety — all of which feed VH. Eliminate during the protocol-establishment phase; reintroduce in modest amounts later if at all.

FODMAPs in excess (during initial protocol)

A 2-4 week low-FODMAP elimination followed by structured reintroduction is reasonable for VH patients with bloating. Do not stay low-FODMAP indefinitely — it reduces microbiome diversity and rarely helps long-term. See the Foods for Visceral Sensitivity guide for the structured approach.

Aggressive elimination diets without structured reintroduction

"I have figured out my food triggers" usually devolves into eating 8 foods. This narrows microbiome diversity, increases food-related anxiety, and rarely solves the underlying VH. Use structured elimination-reintroduction protocols.

Stimulant laxatives (senna, bisacodyl) for chronic constipation

If your VH overlaps with constipation, magnesium and Tier 2 supplements (peppermint oil, motility support) are the right approach. Chronic stimulant laxative use trains the colon away from native motility.

Daily benzodiazepines or opioids for chronic gut pain

These are not the answer for VH. Opioids in particular worsen gut motility and produce narcotic bowel syndrome that mimics worsening pain. Benzodiazepines should be reserved for short-term acute use. Address pain via the supplement stack, gut-brain interventions, and where needed, tricyclics or SSRIs.

"I just need to ignore the pain and push through"

This mindset paradoxically reinforces central sensitization. Anti-coping (denying or suppressing pain awareness) increases pain over time. Pacing, validating, and addressing pain through the stack is more effective than ignoring it.

Excessive abdominal palpation or "checking" behavior

Some VH patients develop a pattern of frequent abdominal palpation, checking for distension, or monitoring discomfort throughout the day. This is a hypervigilance pattern that amplifies symptoms. Awareness without constant checking is part of the gut-brain protocol.

Sample 6-Week Stacking Schedule

The schedule below is a longer ramp than other patterns because VH responds slowly and additions need careful attribution in a noisy symptom environment.

Week 1-2 — Foundation core (peppermint oil + magnesium)

Before main meals (30 min): Enteric-coated peppermint oil 0.2 mL (1 capsule of IBgard or similar).

Before bed: Magnesium glycinate 300 mg.

Lifestyle: Begin daily 15-minute breathwork or meditation practice. Begin gut-directed hypnotherapy via Nerva or in-person therapist.

What to expect: Subtle. Sleep may improve in week 1. Pain episodes may reduce in frequency by week 3-4.

Week 3-4 — Add B. infantis

Add Align (Bifidobacterium infantis 35624) 1 capsule once daily.

Continue peppermint oil and magnesium. Continue hypnotherapy practice (daily session via app or weekly with therapist).

Week 5-6 — Add Iberogast and L-glutamine

Add Iberogast 20 drops 3x daily before meals.

Add L-glutamine 5 g twice daily on empty stomach.

Continue all prior.

Week 7-8 — Assess and add Tier 2 if needed

If pain has reduced 50%+: maintain stack and continue. If pain has reduced less than 50%: add saffron 28 mg AM, then PEA 600 mg AM, then high-EPA omega-3 in successive 2-week additions.

Week 9-12 — Optimize

Steady-state stack typically includes: peppermint oil before meals, magnesium glycinate PM, B. infantis daily, Iberogast for some, L-glutamine for 12-week course (then taper). Continue hypnotherapy maintenance practice.

Long-term:

Many VH patients maintain peppermint oil, magnesium, and B. infantis as long-term core. Iberogast and L-glutamine often used in courses rather than continuously. Hypnotherapy maintenance practice (10-15 min several times per week) is sustainable indefinitely.

Drug Interactions & Common Combinations

SSRIs and SNRIs

Compatible with most of the stack. Saffron and curcumin have mild serotonergic effects; discuss with prescriber when combining. Avoid 5-HTP (not in this guide) with SSRIs.

Tricyclic antidepressants (amitriptyline, nortriptyline)

The supplement stack and low-dose TCAs work well together. Magnesium and TCAs both have sleep effects; some patients can reduce TCA dose once magnesium is established.

Antispasmodics (dicyclomine, hyoscyamine)

Peppermint oil and antispasmodics can be combined but often peppermint oil makes prescription antispasmodics redundant.

Anticoagulants

Omega-3 and curcumin have mild antiplatelet effects. Monitor with prescriber.

Linaclotide, lubiprostone, eluxadoline (IBS-specific medications)

Compatible with the stack. Coordinate timing with prescriber.

Antibiotics (rifaximin, etc.)

Pause probiotics during antibiotic course (separate by 2-3 hours from each dose), restart 24-48 hours after last antibiotic dose.

PPIs and H2 blockers

The Tier 1 stack is generally compatible. If reflux or upper-GI overlap, see the Upper-GI Reflux guide for combined approach.

Cost-Tier Shopping: Budget, Standard, & Premium

Budget tier (~$70-100/month)

• Pepogest enteric-coated peppermint oil — $15
• Magnesium glycinate generic — $10
• Align (B. infantis 35624) — $25
• L-glutamine powder — $15
• Nerva app subscription — $15/mo

Standard tier (~$120-180/month)

• IBgard sustained-release peppermint — $35
• Magnesium glycinate (Pure Encapsulations) — $20
• Align — $25
• Iberogast — $40
• L-glutamine — $20
• Nerva app — $15

Premium tier (~$250-350/month)

• IBgard — $35
• Magnesium glycinate (high-quality) — $25
• Align — $25
• Iberogast — $40
• L-glutamine — $25
• Saffron (Affron-standardized) — $30
• PEA (PeaPure or Normast) — $50
• Curcumin (Meriva) — $35
• Omega-3 (high-EPA, IFOS) — $40
• Nerva + therapist sessions — $50-200/mo

How to Know Your Stack Is Working

Track these metrics over 8-12 weeks. VH improvement is gradual and incremental — week-to-week variation is high. Look at 2-4 week trends rather than day-to-day comparisons.

Pain metrics

• Pain episode frequency (count per week) — target 50%+ reduction
• Pain severity per episode (0-10 scale) — target reduction in peak severity
• Pain duration per episode (minutes-to-hours)
• Pain-free days per week
• Use of as-needed antispasmodics or pain medications

Functional metrics

• Days with no GI-related restriction of activities
• Days with comfortable eating without anticipatory anxiety
• Sleep quality (5-point scale)
• Anxiety related to gut symptoms (5-point scale)
• Overall quality of life (IBS-QOL questionnaire if motivated)

Standardized scores

• IBS Severity Scoring System (IBS-SSS) — administer monthly
• Visual Analog Scale for abdominal pain

Severe Chronic-Pain-IBS Intensive Protocol

For VH patients with daily significant pain (greater than 6/10) that has not adequately responded to 12 weeks of Tier 1-2 plus gut-directed hypnotherapy, this intensive protocol layers all available evidence-based interventions and is best coordinated with a gastroenterologist or pain specialist.

Phase 1 — Comprehensive medication and supplement layering (Weeks 1-8)

• Maximum Tier 1: IBgard 0.2 mL 3x daily, Align daily, Iberogast 20 drops 3x daily, L-glutamine 10 g daily, magnesium glycinate 400 mg PM
• Add Tier 2: Saffron 28 mg AM, PEA 1,200 mg/day split, curcumin 500 mg twice daily, omega-3 3,000 mg/day
• If not already on: low-dose TCA (amitriptyline 10-25 mg) or SSRI (sertraline, escitalopram) per gastroenterology recommendation
• Begin or intensify gut-directed hypnotherapy (Nerva app daily + weekly in-person therapy if accessible)
• Begin CBT for IBS via Mahana or in-person CBT therapist familiar with IBS

Phase 2 — Address SIBO/dysbiosis if present (Weeks 9-12)

• Breath test for SIBO if not already done; rifaximin 550 mg 3x daily for 14 days if positive (prescription)
• Add berberine 500 mg 3x daily concurrent with or following rifaximin
• Add Saccharomyces boulardii 10 billion CFU daily during this phase

Phase 3 — Pelvic floor and structural reassessment (Weeks 13-16)

• Pelvic floor physical therapy evaluation — 30-50% of severe IBS-pain patients have an unaddressed pelvic floor dysfunction component
• For women: gynecology consult to evaluate for endometriosis
• Reassess imaging if symptoms have evolved

Phase 4 — Long-term integration (Months 5+)

• De-escalate to a sustainable maintenance stack — typically: peppermint oil, magnesium, Align, low-dose TCA or SSRI if it helped, periodic L-glutamine and Iberogast courses, maintenance hypnotherapy practice
• Annual review with gastroenterology

When to seek further care

Refer to gastroenterology for: new alarm features (weight loss, blood in stool, fever, family history of IBD or colorectal cancer), pain pattern change, failed response to comprehensive protocol after 16 weeks, or any concern for missed diagnosis. Consider referral to a multidisciplinary IBS/functional GI clinic where available — these provide integrated medication, dietary, behavioral, and pelvic floor care.

Frequently Asked Questions

Build Your Personalized Visceral Sensitivity Plan

The supplement protocol in this guide is the most evidence-based starting point for a visceral-sensitivity gut. But your symptom profile is unique — your pattern combination, your bowel-pattern subtype (IBS-C, IBS-D, IBS-M), your post-infectious history, your stress and mood overlap, and your medication list all shape what will work best for you. The GutIQ quiz takes the framework above and personalizes it to your specific physiology, with a tailored supplement plan, hypnotherapy and CBT recommendations, and a monitoring roadmap.

Medical Disclaimer

This guide is for educational purposes and does not constitute medical advice. Abdominal pain can share features with serious conditions including inflammatory bowel disease, celiac disease, endometriosis, pelvic floor dysfunction, ovarian or pelvic neoplasm, chronic pancreatitis, interstitial cystitis, and structural disorders requiring surgical evaluation. If you have not been evaluated by a healthcare provider, if you have alarm features (unintentional weight loss, blood in stool, fever, dramatic change in pain character, family history of IBD or colorectal cancer), or if symptoms persist or worsen despite a 12-week well-conducted protocol, see a gastroenterologist. The supplements and doses in this guide assume normal kidney and liver function and no significant medication interactions. Low-dose tricyclic antidepressants, SSRIs, rifaximin, linaclotide, lubiprostone, and eluxadoline are prescription medications requiring medical supervision. Pregnancy and lactation require separate guidance. Brand examples are illustrative; choose based on quality marks and third-party testing. Evidence summaries reflect literature current as of April 2026.